Economic Evaluations of Gestational Diabetes Mellitus Screening: A Systematic Review
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
BACKGROUND: This study aims to find evidence of the cost-effectiveness of gestational diabetes mellitus (GDM) screening and assess the quality of current economic evaluations, which have shown different conclusions with a variation in screening methods, data sources, outcome indicators, and implementation in diverse organizational contexts. METHODS: Embase, Medline, Web of Science, Health Technology Assessment, database, and National Health Service Economic Evaluation Database databases were searched through June 2019. Studies on economic evaluation reporting both cost and health outcomes of GDM screening programs in English language were selected, and the quality of the studies was assessed using Drummond's checklist. The general characteristics, main assumptions, and results of the economic evaluations were summarized. RESULTS: Our search yielded 10 eligible economic evaluations with different screening strategies compared in different settings and perspectives. The selected papers scored 81% (68-97%) on the items in Drummond's checklist on average. In general, a screening program is cost-effective or even dominant over no screening. The one-step screening, with more cases detected, is more likely to be cost-effective than the two-step screening. Universal screening is more likely to be cost-effective than screening targeting the high-risk population. Parameters affecting cost-effectiveness include: diagnosis criteria, epidemiological characteristics of the population, efficacy of screening and treatment, and costs. CONCLUSIONS: Most studies found GDM screening to be cost-effective, though uncertainties remain due to many factors. The quality assessment identified weaknesses in the economic evaluations in terms of integrating existing data, measuring costs and consequences, analyzing perspectives, and adjusting for uncertainties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A systematic review of economic evaluations of GDM screening found that the one-step method identi fi ed more cases of GDM and was more likely to be costeffective than the two-step method (229).”
From 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024 (2024) · cites this paper as [229]
The cited source says what the claim attributes to it.
In the citing paper
“A systematic review of economic evaluations of GDM screening found that the one-step method identified more cases of GDM and was more likely to be cost-effective than the two-step method (211).”
From 2. Diagnosis and classification of diabetes: standards of care in diabetes-2025 (2025) · cites this paper as [211]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Updating cost-effectiveness—the curious resilience of the $50,000-per-QALY threshold
Neumann, P. J., Cohen, J. T., & Weinstein, M. C. (2014) · New England Journal of Medicine · doi:10.1056/nejmp1405158 · Cited by 2,249
Thresholds for the cost–effectiveness of interventions: alternative approaches
Marseille, E., Larson, B., Kazi, D. S., Kahn, J. G., & Rosen, S. (2015) · Bulletin of the World Health Organization · doi:10.2471/blt.14.138206 · Cited by 851
Sacks, D. A., Hadden, D. R., Maresh, M., Deerochanawong, C., Dyer, A. R., Metzger, B. E., Lowe, L. P., Coustan, D. R., Hod, M., Oats, J. J. N., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1641 · Cited by 687
Prediction of gestational diabetes mellitus by maternal factors and biomarkers at 11 to 13 weeks
Nanda, S., Savvidou, M., Syngelaki, A., Akolekar, R., & Nicolaides, K. H. (2011) · Prenatal Diagnosis · doi:10.1002/pd.2636 · Cited by 254
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-80 · Cited by 231
Offspring of diabetic pregnancy: Long-term outcomes
Simeoni, U., & Barker, D. J. (2009) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2009.01.002 · Cited by 189
Ziegler, A.-G., Wallner, M., Kaiser, I., Rossbauer, M., Harsunen, M. H., Lachmann, L., Maier, J., Winkler, C., & Hummel, S. (2012) · Diabetes · doi:10.2337/db12-0393 · Cited by 183 · cited 1×
“Review Article J Epidemiol 2021;31(3):220-230 Economic Evaluations of Gestational Diabetes Mellitus Screening: A Systematic Review Xiuting Mo1,2, Ruoyan Gai Tobe1,3, Yoshimitsu Takahashi2, Naoko Arata4, Tippawan Liabsuetrakul5, Takeo Nakayama2, and Rintaro Mori1 1Department of Health Policy, National Center for Child…”
BackgroundWerner, E. F., Pettker, C. M., Zuckerwise, L., Reel, M., Funai, E. F., Henderson, J., & Thung, S. F. (2012) · Diabetes Care · doi:10.2337/dc11-1643 · Cited by 182
Mitanchez, D., Burguet, A., & Siméoni, U. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.10.076 · Cited by 134
Effect of Treatment of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis
Poolsup, N., Suksomboon, N., & Amin, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092485 · Cited by 118
Gestational diabetes screening with the new IADPSG guidelines: a cost-effectiveness analysis
Mission, J. F., Ohno, M. S., Cheng, Y. W., & Caughey, A. B. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.06.048 · Cited by 111
Screening tests for gestational diabetes in Japan in the 1st and 2nd trimester of pregnancy
Maegawa, Y., Sugiyama, T., Kusaka, H., Mitao, M., & Toyoda, N. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00146-3 · Cited by 85
Syngelaki, A., Pastides, A., Kotecha, R., Wright, A., Akolekar, R., & Nicolaides, K. H. (2015) · Fetal Diagnosis and Therapy · doi:10.1159/000369970 · Cited by 83
Marseille, E., Lohse, N., Jiwani, A., Hod, M., Seshiah, V., Yajnik, C. S., Arora, G. P., Balaji, V., Henriksen, O., Lieberman, N., et al. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.765845 · Cited by 76
Is first-trimester HbA1c useful in the diagnosis of gestational diabetes?
Benaiges, D., Roux, J. A. F., Marcelo, I., Mañé, L., Rodríguez, M. Á., Navarro, X., Chillarón, J. J., Llauradó, G., Gortazar, L., Pedro‐Botet, J., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.08.019 · Cited by 64
Cade, T. J., Polyakov, A., & Brennecke, S. P. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-023293 · Cited by 59
Cost-effectiveness of controlling gestational diabetes mellitus: a systematic review
Fitria, N., van Asselt, A. D. I., & Postma, M. J. (2019) · The European Journal of Health Economics · doi:10.1007/s10198-018-1006-y · Cited by 58
Benefits of probabilistic sensitivity analysis – a review of NICE decisions
Adalsteinsson, E., & Toumi, M. (2013) · Journal of Market Access & Health Policy · doi:10.3402/jmahp.v1i0.21240 · Cited by 57
Screening for gestational diabetes: variation in guidelines
Vogel, N., Burnand, B., Vial, Y., Ruiz, J., Paccaud, F., & Hohlfeld, P. (2000) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(99)00248-1 · Cited by 55
Lohse, N., Marseille, E., & Kahn, J. G. (2011) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(11)60007-6 · Cited by 54
Round, J. A., Jacklin, P., Fraser, R. B., Hughes, R. G., Mugglestone, M. A., & Holt, R. I. G. (2010) · Diabetologia · doi:10.1007/s00125-010-1881-y · Cited by 49
Screening for Gestational Diabetes Mellitus
Nicholson, W. K., Fleisher, L. A., Fox, H. E., & Powe, N. R. (2005) · Diabetes Care · doi:10.2337/diacare.28.6.1482 · Cited by 45
Rey, É., Hudon, L., Michon, N., Boucher, P., Éthier, J., & Saint-Louis, P. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.05.018 · Cited by 43
Cost-effectiveness analysis of gestational diabetes mellitus screening in France
Poncet, B., Touzet, S., Rocher, L., Berland, M., Orgiazzi, J., & Colin, C. (2002) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(02)00042-8 · Cited by 43
Caissutti, C., & Berghella, V. (2017) · BioMed Research International · doi:10.1155/2017/2746471 · Cited by 36
Screening for gestational diabetes mellitus: recommendations and rationale
U.S. Preventive Services Task Force (2003) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)03056-9 · Cited by 34
Cianni, G. D., Volpe, L., Casadidio, I., Bottone, P., Marselli, L., Lencioni, C., Boldrini, A., Teti, G. C., Prato, S. D., & Benzi, L. (2002) · Acta Diabetologica · doi:10.1007/s005920200016 · Cited by 34
Health Care System Information Sharing: A Step Toward Better Health Globally
Eldessouki, R., & Smith, M. D. (2012) · Value in Health Regional Issues · doi:10.1016/j.vhri.2012.03.022 · Cited by 32
Jacklin, P. B., Maresh, M. J., Patterson, C. C., Stanley, K. P., Dornhorst, A., Burman-Roy, S., & Bilous, R. W. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016621 · Cited by 31
Danyliv, A., Gillespie, P., O’Neill, C., Tierney, M., O’Dea, A., McGuire, B. E., Glynn, L. G., & Dunne, F. (2015) · Diabetologia · doi:10.1007/s00125-015-3824-0 · Cited by 28
Sortsø, C., Komkova, A., Sandbæk, A., Griffin, S. J., Emneus, M., Lauritzen, T., & Simmons, R. K. (2018) · Diabetologia · doi:10.1007/s00125-018-4594-2 · Cited by 28
Werbrouck, A., Schmidt, M., Putman, K. D., Benhalima, K., Verhaeghe, N., Annemans, L., & Simoens, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.11.012 · Cited by 22
Cost Efficacy of Routine Screening for Diabetes in Pregnancy: 1-h Versus 2-h Specimen
Weiner, C. P., Fraser, M., Burns, J., Schnoor, D., Herrig, J. E., & Whitaker, L. A. (1986) · Diabetes Care · doi:10.2337/diacare.9.3.255 · Cited by 21
Ayach, W., Costa, R., Calderon, I. D. M. P., & Rudge, M. V. C. (2006) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802006000100002 · Cited by 21
Chen, P. Y., Finkelstein, E. A., Ng, M. J., Yap, F. K. P., Yeo, G. S., Rajadurai, V. S., Chong, Y. S., Gluckman, P. D., Saw, S., Kwek, K. Y. C., et al. (2015) · Asia Pacific Journal of Public Health · doi:10.1177/1010539515612908 · Cited by 20
Diagnosing the doctors' departure: survey on sources of dissatisfaction among Irish junior doctors.
Gillespie, P., O'Neill, C., Avalos, G., & Fp, D. (2012) · PubMed · Cited by 16
Walker, A. R., & Caughey, A. B. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1716213 · Cited by 11
Cost-effectiveness of the New Zealand diabetes in pregnancy guideline screening recommendations
Coop, C., Edlin, R. P., Brown, J., & Farquhar, C. M. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-006996 · Cited by 10
Rodríguez-Pérez, M., Orozco-Beltrán, D., Gil-Guillén, V., Domínguez-Coello, S., Almeida-González, D., Brito-Díaz, B., Marcelino-Rodriguez, I., Carratalá-Munuera, M., Gómez-Moreno, N., Navarro-Pérez, J., et al. (2017) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2017.05.009 · Cited by 7
Cost-Effectiveness Analysis of Gestational Diabetes Mellitus Screening in Urban Chinese Setting
Zhang, L., Chen, W., Wang, Y., Ma, R., Du, M., & Xu, X. (2015) · Value in Health · doi:10.1016/j.jval.2015.09.2099 · Cited by 6
Lee, S., Pettker, C. M., Funai, E. F., Norwitz, E. R., & Thung, S. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.09.725 · Cited by 4
Mission, J. F., Ohno, M. S., Yanit, K., Cheng, Y. K. Y., & Caughey, A. B. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.10.275 · Cited by 3
Thung, S., Pettker, C. M., & Funai, E. F. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.10.372 · Cited by 2
Reel, M., Werner, E. F., Pettker, C. M., Funai, E. F., & Thung, S. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.10.298 · Cited by 1
264: Cost-effectiveness analysis of screening for GDM
van Leeuwen, M., Vijgen, S. M. C., Opmeer, B. C., Evers, I. M., & Mol, B. W. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.10.279 · Cited by 1
Werner, E. F., Pettker, C. M., Reel, M., Zuckerwise, L. C., Funai, E. F., & Thung, S. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.10.268 · Cited by 1
Pearson, L. J., Mission, J. F., Niu, B., & Caughey, A. B. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.10.336 · Cited by 1
Quitian, H., Acosta, A. M., Martinez, R., Peñaranda, A. P. B., Cajamarca, J., Amado, L., Gómez–Restrepo, C., & Rosselli, D. (2015) · Value in Health · doi:10.1016/j.jval.2015.09.2115 · Cited by 1
Gestational Diabetes Screening for Chinese Women: A Cost-Effectiveness Analysis
Ming, W. (2016) · Value in Health · doi:10.1016/j.jval.2016.08.208 · Cited by 1
Walker, A. R., Valent, A. M., & Caughey, A. B. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.11.229 · Cited by 1
PDB58 GESTATIONAL DIABETES SCREENING IN CHINA: A COST-EFFECTIVENESS STUDY
Liang, S., He, Z., Tang, Y., Xie, H., Xiao, X. M., Chen, Z., Xu, Y. Y., & Ming, W. (2019) · Value in Health · doi:10.1016/j.jval.2019.04.607 · Cited by 1
Research works printed but not linked: 6
- Duarte A, Griffin S, Sheldon T, Identification and treatment of gestational diabetes: an economic evaluation. BJOG. 2018; 125: 112– 113.
- Li LJ, Aris IM, Chong Y, Gluckman P, Ang S, Tan K Comparison of diagnostic value and cost-effectiveness in screening approaches for postpartum pre-diabetes and diabetes among women with history of gestational diabetes. Diabetologia. 2018; 61: S458.
- Duran A, Saenz S, Torrejon MJ, IADPSG criteria for screening and diagnosis of gestational diabetes mellitus (GDM) induce better outcomes of pregnancy with a lower cost in a large cohort of pregnant women. Diabetes. 2014; 63: A338– A339.
- Gillespie P, O’Neill C, Avalos G, Dunne FP; ALANTIC DIP Collaborators New estimates of the costs of universal screening for gestational diabetes mellitus in Ireland. Ir Med J. 2012; 105(5 Suppl): 15– 18. 22838102
- Larijani B, Hossein-Nezhad A, Vassigh AR Effect of varying threshold and selective versus universal strategies on the cost in gestational diabetes mellitus. Arch Iran Med. 2004; 7(4): 267– 271.
- Excellence NIfC. Guide to the methods of technology appraisal 2013. https://www.nice.org.uk/process/pmg9/chapter/foreword. 2013. 27905712
Cited by
2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Gaglia, J. L., Hilliard, M. E., Isaacs, D., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s002 · Cited by 2,433
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s002 · Cited by 2,086
2. Diagnosis and classification of diabetes: standards of care in diabetes-2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Ebekozien, O., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s002 · Cited by 1,393
2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s002 · Cited by 473
Epidemiology and management of gestational diabetes
Sweeting, A., Hannah, W., Backman, H., Catalano, P., Feghali, M., Herman, W. H., Hivert, M.-F., Immanuel, J., Meek, C., Oppermann, M. L., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00825-0 · Cited by 431
Metadata
- Authors
- Mo, X., Gai Tobe, R., Takahashi, Y., Arata, N., Liabsuetrakul, T., Nakayama, T., & Mori, R.
- Affiliations
- Kyoto University (JP)
- Department of Health Policy, National Center for Child Health and Development
- National Center For Child Health and Development (JP)
- Prince of Songkla University (TH)
- ORCID
- Venue
- Journal of Epidemiology
- Publisher
- Japan Epidemiological Association
- Published
- 2021-03-05
- Volume
- 31
- Issue
- 3
- Pages
- 220-230
- ISSN
- 0917-5040 (ISSN-L)
- 1349-9092
- PMC
- PMC7878709
- OpenAlex
- W3027273330
- Cited by
- 29
- References
- 52
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 8 · 2023: 3 · 2022: 8 · 2021: 1
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Epidemiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion, cc-by)
- Funders
- Japan Society for the Promotion of Science (18J22137)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- gestational diabetes mellitus, prenatal screening, cost-effectiveness, economic evaluation quality, universal screening, high-risk population screening, health technology assessment
- MeSH terms
- Cost-Benefit Analysis, Female, Humans, Mass Screening, Pregnancy, Diabetes, Gestational
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.